Key result
Alzheimer disease-associated PBA is linked to ~152% higher depression risk and greater anxiety than stroke-associated PBA.
Why the study?
Depression and anxiety frequently co-occur with pseudobulbar affect, but whether psychiatric outcomes differ by neurological etiology remains unclear.
Does the risk of depressive episodes and anxiety disorders differ between stroke-associated and Alzheimer disease-associated pseudobulbar affect?
Does the risk of depressive episodes and anxiety disorders differ between stroke-associated and Alzheimer disease-associated pseudobulbar affect?
Alzheimer disease-associated pseudobulbar affect confers a significantly higher and earlier risk of subsequent depression and anxiety compared to stroke-associated pseudobulbar affect.
Answers are grounded in this paper and cite their sources.
May support closer depression monitoring in Alzheimer disease with pseudobulbar affect; leaves open whether the association is causal or warrants practice change.
Introduction: Pseudobulbar affect (PBA) is a disorder of emotional expression associated with neurological diseases, including stroke and Alzheimer disease. Depression and anxiety frequently co-occur, but whether psychiatric outcomes differ by neurological etiology remains unclear. Objective: To compare the risk and timing of depressive episodes and anxiety disorders in stroke-associated versus Alzheimer disease-associated PBA. Methods: We conducted a retrospective cohort study using the TriNetX Global Health Research Network (2020 to 2025). Two mutually exclusive cohorts were identified: PBA with stroke and PBA with Alzheimer disease. Outcomes were depressive episode (ICD-10-CM F32) and anxiety disorder, unspecified (ICD-10-CM F41.9), occurring after PBA diagnosis. One-to-one propensity score matching was performed for age, sex, race, and ethnicity. Kaplan-Meier analyses and Cox proportional hazards models assessed risk and timing. Results: After matching, 1074 patients per cohort were included for depression analysis. Depression occurred in 68.7% of Alzheimer disease-PBA versus 34.7% of stroke-PBA (absolute risk difference 34.0%, P <0.001; HR=2.52, 95% CI: 2.22-2.86). For anxiety (n=946 per cohort), rates were 48.8% versus 24.9% (absolute risk difference 23.9%, P <0.001; HR=1.98, 95% CI: 1.70-2.30). Conclusion: Alzheimer disease-associated PBA confers a higher and earlier risk of depression and anxiety, supporting enhanced psychiatric screening in neurodegenerative disease.
No takes yet. Share an insight, caveat, or question.
Dereschuk et al. (2026) studied this question. Alzheimer disease-associated pseudobulbar affect conferred a higher risk of depression and anxiety than stroke-associated PBA.
Synapse has enriched 10 related papers. Consider them for comparative context: